Cargando…
Vasoactive intestinal peptide exerts therapeutic action by regulating PTEN in a model of Sjögren's disease
INTRODUCTION: Sjögren's disease (SjD) is a chronic autoimmune disease characterized by the loss of the secretory function of the exocrine glands. At present, drugs that can both correct the immune imbalance and improve exocrine gland function are needed. Meanwhile, vasoactive intestinal peptide...
Autores principales: | Li, Yixi, Zhu, Wen, Lin, Rui, Zhao, Junjie, Wang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336679/ https://www.ncbi.nlm.nih.gov/pubmed/37506142 http://dx.doi.org/10.1002/iid3.936 |
Ejemplares similares
-
Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide
Publicado: (1987) -
Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016) -
Therapeutic effect of vasoactive intestinal peptide on form-deprived amblyopic kittens
por: Li, Bo, et al.
Publicado: (2019) -
The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation
por: Qu, Hongyi, et al.
Publicado: (2021) -
Vasoactive intestinal peptide secreting tumour: An overview
por: Una Cidon, Esther
Publicado: (2022)